Chemoinformaics analysis of Epsilon-N-Methyl-Lysine
| Molecular Weight | 160.217 | nRot | 6 |
| Heavy Atom Molecular Weight | 144.089 | nRig | 1 |
| Exact Molecular Weight | 160.121 | nRing | 0 |
| Solubility: LogS | -0.841 | nHRing | 0 |
| Solubility: LogP | -3.397 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 26.1627 |
| nHD | 3 | BPOL | 16.9193 |
| QED | 0.47 |
| Synth | 2.527 |
| Natural Product Likeliness | 1.208 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.006 |
| HIA | 0.339 |
| CACO-2 | -5.875 |
| MDCK | 0.000305537 |
| BBB | 0.367 |
| PPB | 0.101419 |
| VDSS | 0.902 |
| FU | 0.984507 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.052 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.097 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.283 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.031 |
| CL | 7.598 |
| T12 | 0.537 |
| hERG | 0.034 |
| Ames | 0.026 |
| ROA | 0.123 |
| SkinSen | 0.643 |
| Carcinogencity | 0.05 |
| EI | 0.061 |
| Respiratory | 0.64 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.944676 |